<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Wu H</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Use our advanced, physiologically inspired cardiac CT perfusion (CCTP) software to distinguish ischemia due to obstructive disease vs. microvascular disease (MVD).&lt;h4>Background&lt;/h4>Previously validated advanced CCTP methods were used. We interpreted results to identify flow-limiting stenosis [i.e., obstructive-lesion &amp; low myocardial blood flow (MBF)] vs. microvascular disease (i.e., no-obstructive-lesion &amp; low-MBF).&lt;h4>Methods&lt;/h4>We retrospectively evaluated 104 patients with suspected CAD, including 18 with diabetes, who underwent CCTA + CCTP. Whole heart and territorial MBF was assessed using our automated pipeline for CCTP analysis that included beam hardening correction; temporal scan registration; automated segmentation; fast, accurate, robust MBF estimation; and visualization. Stenosis severity was scored using the CCTA coronary-artery-disease-reporting-and-data-system (CAD-RADS), with obstructive stenosis deemed as CAD-RADS ≥ 3.&lt;h4>Results&lt;/h4>We established a threshold MBF (MBF = 200-mL/min-100 g) for normal perfusion. In patients with CAD-RADS ≥ 3 (obstructive disease), 28/37(76%) patients showed ischemia in the corresponding territory. On a per-vessel basis (&lt;i>n&lt;/i> = 256), MBF showed a significant difference between territories with and without obstructive stenosis (165 ± 61 mL/min-100 g vs. 274 ± 62 mL/min-100 g, &lt;i>p&lt;/i> &lt; 0.05). A significant negative rank correlation (&lt;i>ρ&lt;/i> = -0.53, &lt;i>p&lt;/i> &lt; 0.05) between territory MBF and CAD-RADS was seen. Two patients with obstructive disease had normal perfusion, suggesting collaterals and/or hemodynamically insignificant stenosis. Among diabetics, 10 of 18 (56%) demonstrated diffuse ischemia consistent with MVD. Among non-diabetics, only 6% had MVD. Sex-specific prevalence of MVD was 21%/24% (M/F).&lt;h4>Conclusion&lt;/h4>CCTA in conjunction with a new automated quantitative CCTP approach can determine the distinction of ischemia due to obstructive lesions vs. MVD.</pubmed_abstract><journal>Frontiers in cardiovascular medicine</journal><pagination>1621443</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12640952</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Quantitative cardiac CT perfusion: physiologically-inspired model and identifying microvascular disease from discordant CTA CAD-RADS.</pubmed_title><pmcid>PMC12640952</pmcid><pubmed_authors>Al-Kindi S</pubmed_authors><pubmed_authors>Yun CH</pubmed_authors><pubmed_authors>Rajagopalan S</pubmed_authors><pubmed_authors>Hung CL</pubmed_authors><pubmed_authors>Lee J</pubmed_authors><pubmed_authors>Huang WM</pubmed_authors><pubmed_authors>Wilson DL</pubmed_authors><pubmed_authors>Hoori A</pubmed_authors><pubmed_authors>Wu H</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantitative cardiac CT perfusion: physiologically-inspired model and identifying microvascular disease from discordant CTA CAD-RADS.</name><description>&lt;h4>Objective&lt;/h4>Use our advanced, physiologically inspired cardiac CT perfusion (CCTP) software to distinguish ischemia due to obstructive disease vs. microvascular disease (MVD).&lt;h4>Background&lt;/h4>Previously validated advanced CCTP methods were used. We interpreted results to identify flow-limiting stenosis [i.e., obstructive-lesion &amp; low myocardial blood flow (MBF)] vs. microvascular disease (i.e., no-obstructive-lesion &amp; low-MBF).&lt;h4>Methods&lt;/h4>We retrospectively evaluated 104 patients with suspected CAD, including 18 with diabetes, who underwent CCTA + CCTP. Whole heart and territorial MBF was assessed using our automated pipeline for CCTP analysis that included beam hardening correction; temporal scan registration; automated segmentation; fast, accurate, robust MBF estimation; and visualization. Stenosis severity was scored using the CCTA coronary-artery-disease-reporting-and-data-system (CAD-RADS), with obstructive stenosis deemed as CAD-RADS ≥ 3.&lt;h4>Results&lt;/h4>We established a threshold MBF (MBF = 200-mL/min-100 g) for normal perfusion. In patients with CAD-RADS ≥ 3 (obstructive disease), 28/37(76%) patients showed ischemia in the corresponding territory. On a per-vessel basis (&lt;i>n&lt;/i> = 256), MBF showed a significant difference between territories with and without obstructive stenosis (165 ± 61 mL/min-100 g vs. 274 ± 62 mL/min-100 g, &lt;i>p&lt;/i> &lt; 0.05). A significant negative rank correlation (&lt;i>ρ&lt;/i> = -0.53, &lt;i>p&lt;/i> &lt; 0.05) between territory MBF and CAD-RADS was seen. Two patients with obstructive disease had normal perfusion, suggesting collaterals and/or hemodynamically insignificant stenosis. Among diabetics, 10 of 18 (56%) demonstrated diffuse ischemia consistent with MVD. Among non-diabetics, only 6% had MVD. Sex-specific prevalence of MVD was 21%/24% (M/F).&lt;h4>Conclusion&lt;/h4>CCTA in conjunction with a new automated quantitative CCTP approach can determine the distinction of ischemia due to obstructive lesions vs. MVD.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-05T19:32:47.382Z</modification><creation>2026-05-21T03:09:04.334Z</creation></dates><accession>S-EPMC12640952</accession><cross_references><pubmed>41293615</pubmed><doi>10.3389/fcvm.2025.1621443</doi></cross_references></HashMap>